Introduction: Preventable rheumatic heart disease (RHD) deaths continue to occur in Australia, with Aboriginal people disproportionately affected. Despite research into structural drivers and the lived experience of people with RHD, and national guidelines focusing on RHD prevention and treatment, recent coronial inquests have highlighted that systemic failures are ongoing. Few studies describe RHD service delivery and/or mortality within the Western Australian (WA) context.
Objective: This study aimed to integrate quantitative information regarding RHD-related deaths in WA between 2012 and 2021 with qualitative interview data to identify system-level opportunities for the prevention of RHD-related mortality in the WA health care setting.
Design: Using quantitative data from the WA RHD register, a descriptive analysis of the clinical and demographic characteristics of RHD patients aged < 65 years was conducted, stratified by vital status. Thematic qualitative analysis of RHD stakeholder interviews was conducted in parallel, capturing systemic factors perceived to prevent or contribute to RHD-related mortality in WA.
Findings: Limited health service contacts were documented for the 60 registered-recorded deaths among people with RHD. Interviewees emphasised that access to appropriate care was vital to prevent mortality. Passionate healthcare providers connect patients with care by fostering trusting relationships, but logistical, socio-cultural and care quality barriers continue to hamper connections.
Conclusion: Systemic change is needed in WA to support motivated providers and ensure that efforts to reduce RHD mortality do not rely on individual initiatives. This study contributes evidence for the need to improve RHD program design by prioritising patient-provider connections, empowering, and resourcing providers to effectively engage with RHD patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/ajr.70022 | DOI Listing |
Reumatol Clin (Engl Ed)
February 2025
Rheumatology Department, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
Objective: The aim of this study was to determine the prevalence of cardiovascular risk factors and comorbidities in a cohort of Mexican Mestizo rheumatoid arthritis (RA) patients.
Methods: We performed an observational and cross-sectional study involving the RA cohort of our Cardio-Rheumatology Clinic in a teaching hospital. The cohort includes patients aged 40-75 years old who fulfilled the ACR/EULAR classification criteria for RA, patients were recruited from August 2014 to July 2023.
Rheumatic heart disease remains a major health problem for Aboriginal and Torres Strait Islander peoples. In this Reflection, potential solutions to this lamentable situation are reviewed.
View Article and Find Full Text PDFAust J Rural Health
April 2025
Cardiovascular Epidemiology Research Centre, University of Western Australia, Perth, Australia.
Introduction: Preventable rheumatic heart disease (RHD) deaths continue to occur in Australia, with Aboriginal people disproportionately affected. Despite research into structural drivers and the lived experience of people with RHD, and national guidelines focusing on RHD prevention and treatment, recent coronial inquests have highlighted that systemic failures are ongoing. Few studies describe RHD service delivery and/or mortality within the Western Australian (WA) context.
View Article and Find Full Text PDFEur Heart J Case Rep
March 2025
Department of Cardiology, Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium.
Background: Disseminated infection is a severe condition in immunocompromised patients. Mortality secondary to cardiac infection remains high.
Case Summary: We present a case of a 45-year-old female breast cancer patient who developed endocarditis and myocarditis after receiving the immune checkpoint inhibitor (ICI) pembrolizumab.
Eur Heart J Case Rep
March 2025
Division of Cardiology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
Background: Libman-Sacks endocarditis), a non-bacterial thrombotic endocarditis (NBTE) linked to systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), typically causes valve regurgitation and embolism but can rarely mimic rheumatic mitral stenosis (MS).
Case Summary: This case involves a 59-year-old woman with a history of APS and SLE who presented with worsening dyspnoea and congestive heart failure. Initially, severe mitral regurgitation (MR) due to NBTE resolved with vitamin K antagonist therapy, yet she subsequently developed significant MS with commissural fusion, a rheumatic-like feature.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!